1Department of Home Science, Mahila Mahavidyalaya, Banaras Hindu University, Varanasi, 221005, India
2Department of General Medicine, Institute of Medical Science, Banaras Hindu University, Varanasi, 221005, India
3Department of Physics, G. B. College, Ramgarh, Kaimur-821110 (A Constituent Unit of Veer Kunwar Singh University, Ara) Bihar, India
Objective: The study investigates the link between Hyperuricemia, Body mass index (BMI) and Metabolic syndrome in middle-aged adults, providing insights for future interventions to prevent metabolic syndrome. Methods: A study was conducted between the periods July 2023 to March 2024 at the Department of General Medicine, Sir Sunder Lal Hospital, Banaras Hindu University (BHU), Varanasi, Uttar Pradesh, India among the adults in Eastern Uttar Pradesh and South Bihar. A total of 102 adult subjects aged 35 to 65 years were selected using sampling approach. The data collection included anthropometric measurements (height, weight, body mass index), blood pressure assessment and relevant biochemical investigations, which include fasting blood sugar (FBS), postprandial blood sugar (PPBS), glycated haemoglobin (HbA1c) and serum uric acid (SUA) levels. Furthermore, well-designed interview-based questionnaires were re-used to obtain sociodemographic and lifestyle information. All measurements were conducted under protocols and diagnosis of metabolic syndrome was evaluated based on recognized diagnostic criteria. Statistical analyses were carried out to assess the correlation between hyperuricemia, BMI and metabolic syndrome. A p-value of less than 0.05 was considered statistically significant. Results: The study revealed a significant association between hyperuricemia, increased adiposity and critical components of metabolic risk. Subjects aged between 46 to 55 years showed higher prevalence of increased serum uric acid (SUA) levels along with a maximum occurrence of metabolic irregularities. The dietary patterns and physical activity parameters of subjects were found to be profoundly modified with socio-demographic and lifestyle modifications. Additionally, hyperuricemia revealed a significant association with increased blood pressure and poor glycemic control, emphasizing its potential relation to the initial stage of metabolic syndrome. Conclusion: A systematic approach towards the nutritional pattern and physical activity criterion of subjects was profoundly modified with socio-demographic and lifestyle modifications. As follows, early detection of elevated uric acid levels and lifestyle interventions (diet, exercise, weight control) are essential to prevent the progression of metabolic complications. However, high blood pressure and blood sugar control are also essential for preventing metabolic syndrome consequences. Subjects that approach all of these variables systematically can significantly prevent their risk of suffering from crucial health problems associated with hyperuricemia.
| [1] | Li, W., Wu, H., Han, Y., Wu, H., Lin, Z., & Zhang, B. (2023). Global status and trends in gout research from 2012 to 2021: A bibliometric and visual analysis. Clinical Rheumatology, 42(5), 1371–1388.View Article PubMed |
| [2] | Caron, J. P., Kreher, M. A., Mickle, A. M., Wu, S., Przkora, R., Estores, I. M., & Sibille, K. T. (2022). Intermittent fasting: Potential utility in the treatment of chronic pain across the clinical spectrum. Nutrients, 14(12), 2536.View Article PubMed |
| [3] | Petridou, G. (2023). Pain with a PR problem: Narrating gout-induced pain in the Second Sophistic. In J. Clarke, D. King, & H. Baltussen (Eds.), Pain narratives in Greco-Roman writings: Studies in the representation of physical and mental suffering (pp. 121–144). Brill.View Article |
| [4] | Singh, M., Gupta, P., & Reddy, L. (2022). Hyperuricemia screening camp data: Prevalence and associated risk factors. Journal of Metabolic Syndrome, 12(4), 287–294. |
| [5] | Patel, R., Sharma, A., & Kumar, S. (2023). Prevalence of hyperuricemia in the Indian population: A systematic review. Indian Journal of Public Health, 67(2), 123–135. |
| [6] | Choi, H. K., &Curhan, G. (2007). Independent impact of gout on mortality and risk for coronary heart disease. Circulation, 116(8), 894 900.View Article PubMed |
| [7] | Feig, D. I., Kang, D. H., & Johnson, R. J. (2008). Uric acid and cardiovascular risk. New England Journal of Medicine, 359(17), 1811- 1821.View Article PubMed |
| [8] | Bove, M., Cicero, A. F. G., Veronesi, M., & Borghi, C. (2017). An evidence-based review on urate-lowering treatments: Implications for optimal treatment of chronic hyperuricemia. Vascular Health and Risk Management, 13, 23–28.View Article PubMed |
| [9] | Borghi, C., Agabiti-Rosei, E., Johnson, R. J., Kielstein, J. T., Lurbe, E., Mancia, G., Redon, J., Stack, A. G., &Tsioufis, K. P. (2020). Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. European Journal of Internal Medicine, 80, 1–11.View Article PubMed |
| [10] | Kuwabara, M., Hisatome, I., Ae, R., Kosami, K., Aoki, Y., Andres-Hernando, A., Kanbay, M., &Lanaspa, M. A. (2025). Hyperuricemia: A new cardiovascular risk. Nutrition, Metabolism and Cardiovascular Diseases, 35(3), 103796.View Article PubMed |
| [11] | Kim, I. Y., Han, K. D., Kim, D. H., Eun, Y., Cha, H. S., Koh, E. M., Lee, J., & Kim, H. (2019). Women with metabolic syndrome and general obesity are at a higher risk for significant hyperuricemia compared to men. Journal of Clinical Medicine, 8(6), 837.View Article PubMed |
| [12] | Puig, J. G., & Martinez, M. A. (2008). Hyperuricemia, gout, and the metabolic syndrome. Current Opinion in Rheumatology, 20(2), 187- 191.View Article PubMed |
| [13] | Gong, M., Wen, S., Nguyen, T., Wang, C., Jin, J., & Zhou, L. (2020). Converging relationships of obesity and hyperuricemia with special reference to metabolic disorders and plausible therapeutic implications. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 943–962.View Article PubMed |
| [14] | Choi, H. K., & Ford, E. S. (2007). Prevalence of the metabolic syndrome in individuals with hyperuricemia. The American Journal of Medicine, 120(5), 442–447.View Article PubMed |
| [15] | Chen, H. S. (2011). Clinical implications of the metabolic syndrome and hyperuricemia. Journal of the Chinese Medical Association, 74(12), 527 528.View Article PubMed |
| [16] | Billiet, L., Doaty, S., Katz, J. D., & Velasquez, M. T. (2014). Review of hyperuricemia as new marker for metabolic syndrome. International Scholarly Research Notices, 2014(1), 852954.View Article PubMed |
| [17] | Lee, J. M., Kim, H. C., Cho, H. M., Oh, S. M., Choi, D. P., & Suh, I. (2012). Association between serum uric acid level and metabolic syndrome. Journal of Preventive Medicine and Public Health, 45(3), 181–187.View Article PubMed |
| [18] | Wu, J., Qiu, L., Cheng, X., Xu, T., Wu, W., Zeng, X., Ye, Y., & Li, Y. (2017). Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population. Scientific Reports, 7(1), 5456.View Article PubMed |
| [19] | Roman, Y. M. (2022). Moving the needle in gout management: The role of culture, diet, genetics, and personalized patient care practices. Nutrients, 14(17), 3590.View Article PubMed |
| [20] | Alberti, K. G., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15(7), 539–553.View Article |
| [21] | Grundy, S. M., Brewer, H. B., Jr, Cleeman, J. I., Smith, S. C., Jr, &Lenfant, C. (2004). Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 109(3), 433–438.View Article PubMed |
| [22] | Ford, E. S., Giles, W. H., & Dietz, W. H. (2002). Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA, 287(3), 356–359.View Article PubMed |
| [23] | Krishnan, E., Chen, L., & Schumacher, H. R. (2006). Hyperuricemia and incident hypertension among men with gout. Hypertension, 48(1), 28–33. |
| [24] | Nakanishi, N., Tatara, K., Okamoto, M., Matsuo, H., & Ueshima, H. (2003). Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. European Journal of Epidemiology, 18(6), 523–529.View Article PubMed |
